Cargando…

Angiopoietin-like protein as a novel marker for liver fibrosis in chronic hepatitis B patients with normal to minimally raised ALT

BACKGROUND: For hepatitis B patients who do not meet the treatment criteria recommended by guidelines, therapy decisions depend on hepatic histology. Angiopoietin-like protein 2 (Angptl2) is a mediator of chronic inflammation that contributes to extracellular matrix remodeling. The aim of this study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Yongqiong, Zhao, Hong, Zhou, Jiyuan, Yan, Linlin, Wang, Guiqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622570/ https://www.ncbi.nlm.nih.gov/pubmed/28962551 http://dx.doi.org/10.1186/s12879-017-2728-7

Ejemplares similares

Serum YKL-40 as a biomarker for liver fibrosis in chronic hepatitis B patients with normal and mildly elevated ALT
por: Yan, Linlin, et al.
Publicado: (2018)

Complement 5a is an indicator of significant fibrosis and earlier cirrhosis in patients chronically infected with hepatitis B virus
por: Deng, Yongqiong, et al.
Publicado: (2016)

Serum GP73 - An Additional Biochemical Marker for Liver Inflammation in Chronic HBV Infected Patients with Normal or Slightly Raised ALT
por: Wei, Meijuan, et al.
Publicado: (2019)

Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase
por: Zeng, Da-Wu, et al.
Publicado: (2016)

Diagnostic value of angiopoietin-like protein 2 for CHB-related hepatocellular carcinoma
por: Zhou, Jiyuan, et al.
Publicado: (2019)

Hepatic and portal vein Doppler ultrasounds in assessing liver inflammation and fibrosis in chronic HBV infection with a normal ALT level
por: Tian, Li, et al.
Publicado: (2023)

Lower liver cancer risk with antiviral therapy in chronic hepatitis B patients with normal to minimally elevated ALT and no cirrhosis
por: Hoang, Joseph K., et al.
Publicado: (2016)

Hepatic enzyme ALT as a marker of glucose abnormality in men with cystic fibrosis
por: Colomba, Johann, et al.
Publicado: (2019)

Presence of Liver Inflammation in Asian Patients With Chronic Hepatitis B With Normal ALT and Detectable HBV DNA in Absence of Liver Fibrosis
por: Liu, Jiacheng, et al.
Publicado: (2021)

Significant Fibrosis Is Not Rare in Chinese Chronic Hepatitis B Patients with Persistent Normal ALT
por: Liao, Baolin, et al.
Publicado: (2013)

Angiopoietin-like-4 and minimal change disease
por: Cara-Fuentes, Gabriel, et al.
Publicado: (2017)

Liver Stiffness Measurement and Biochemical Markers in Senegalese Chronic Hepatitis B Patients with Normal ALT and High Viral Load
por: Mbaye, Papa Saliou, et al.
Publicado: (2011)

Blood angiopoietin-2 predicts liver angiogenesis and fibrosis in hepatitis C patients
por: Osawa, Yosuke, et al.
Publicado: (2021)

Angiopoietin-like protein 2 and angiopoietin-like protein 6 levels in patients with nonalcoholic fatty liver disease
por: Erkan, Gulbanu, et al.
Publicado: (2016)

Very low probability of significant liver inflammation in chronic hepatitis B patients with low ALT levels in the absence of liver fibrosis
por: Sonneveld, Milan J., et al.
Publicado: (2020)

Study on liver histopathology of chronic HBV infected patients with different normal ALT values
por: Zeng, Zhan, et al.
Publicado: (2022)

Angiopoietin-like 3 inhibition and the liver: less is more?
por: Oostveen, Reindert F., et al.
Publicado: (2023)

Angiopoietin-like 3 inhibition of endothelial lipase is not modulated by angiopoietin-like 8
por: Sylvers-Davie, Kelli L., et al.
Publicado: (2021)

THU068 Evaluation Of Nonalcoholic Fatty Liver Disease, Liver Fibrosis And Serum Angiopoietin-like Protein Levels In Patients With Acromegaly
por: Eroglu, Imdat, et al.
Publicado: (2023)

Nomogram for evaluating obvious liver inflammation in treatment-naïve HBeAg positive chronic hepatitis B virus infection patients with normal ALT
por: Zhang, Lu, et al.
Publicado: (2023)

Predictive value of FibroScan in detecting liver fibrosis in HBeAg negative patients with chronic hepatitis B whose HBV DNA 2000–20000 IU/ml with ALT 1–2 times the upper limit of normal and those with HBV DNA >20000 IU/ml and normal ALT
por: Danis, Nilay, et al.
Publicado: (2021)

Efficacy evaluation of direct antiviral drugs against hepatitis B virus in improving the degree of liver fibrosis
por: Miao, Liang, et al.
Publicado: (2023)

Angiopoietin-Like4 Is a Novel Marker of COVID-19 Severity
por: Bhatraju, Pavan K., et al.
Publicado: (2022)

Serum hepatitis B core antibody as a biomarker of hepatic inflammation in chronic hepatitis B patients with normal alanine aminotransferase
por: Zhou, Jiyuan, et al.
Publicado: (2017)

Non-ALT biomarkers for markedly abnormal liver histology among Chinese persistently normal alanine aminotransferase-chronic hepatitis B patients
por: Cheng, Jin-Lin, et al.
Publicado: (2017)

Circulating angiopoietin-like 8 (ANGPTL8) is a marker of liver steatosis and is negatively regulated by Prader-Willi Syndrome
por: Mele, Chiara, et al.
Publicado: (2017)

Dysfunction of Immune Systems and Host Genetic Factors in Hepatitis C Virus Infection with Persistent Normal ALT
por: Kondo, Yasuteru, et al.
Publicado: (2011)

Comparison of Histologic Characteristics of Chinese Chronic Hepatitis B Patients with Persistently Normal or Mildly Elevated ALT
por: Wang, Hong, et al.
Publicado: (2013)

Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis
por: Laschtowitz, Alena, et al.
Publicado: (2021)

Air pollution impede ALT normalization in chronic hepatitis B patients treated with nucleotide/nucleoside analogues
por: Jang, Tyng-Yuan, et al.
Publicado: (2023)

Hypoxia-induced interstitial transformation of microvascular endothelial cells by mediating HIF-1α/VEGF signaling in systemic sclerosis
por: Mao, Jing, et al.
Publicado: (2022)

Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C
por: Hernández-Bartolomé, Ángel, et al.
Publicado: (2016)

Spleen thickness can predict significant liver pathology in patients with chronic hepatitis B with persistently normal alanine aminotransferase or minimally raised alanine aminotransferase: a retrospective study
por: Zhang, Junli, et al.
Publicado: (2018)

Targeting Tie-2/angiopoietin axis in experimental mesothelioma confers differential responses and raises predictive implications
por: Magkouta, Sophia, et al.
Publicado: (2018)

Tubular Overexpression of Angiopoietin-1 Attenuates Renal Fibrosis
por: Singh, Sudhir, et al.
Publicado: (2016)

qHBsAg for the Identification of Liver Histological Abnormalities in HBeAg-Negative Chronic Hepatitis B Patients with Normal and Mildly Elevated ALT Levels
por: Gan, Qinyi, et al.
Publicado: (2022)

Distinct Clinical Impact and Biological Function of Angiopoietin and Angiopoietin-like Proteins in Human Breast Cancer
por: Yang, Hui, et al.
Publicado: (2021)

Angiopoietin-Like-4, a Potential Target of Tacrolimus, Predicts Earlier Podocyte Injury in Minimal Change Disease
por: Li, Jian-Si, et al.
Publicado: (2015)

AST/ALT ratio, APRI, and FIB-4 compared to FibroScan for the assessment of liver fibrosis in patients with chronic hepatitis B in Bandar Abbas, Hormozgan, Iran
por: Moosavy, Seyed Hamid, et al.
Publicado: (2023)

Angiopoietin-Like 4 Regulates Epidermal Differentiation
por: Pal, Mintu, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_bb7t1qmua2m18qq2mktp4i06hv